9704 MEDICAL CENTER DRIVE, Rockville, MD
Director Resignation - Karen Ferrante Steps Down from Board
Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
MacroGenics, Inc. Annual Meeting - Stockholder Votes on Director Elections
Reports First Quarter 2026 Financial Results and Highlights Business Transformation
To Sell GMP Manufacturing Operations to Pharmaceuticals
And Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
FDA Removes Partial Clinical Hold on LINNET Study
Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership